Loss of epithelial membrane protein-2 expression confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study
Authors:
Open Access
Abstract
Objective To evaluate the expression of epithelial membrane protein-2 (EMP2) protein and its clinicopathological associations in patients with nasopharyngeal carcinoma. Design Retrospective population-based cohort study. Setting This study was based on a biobank in Chi-Mei Medical Center (Tainan, Taiwan) from 1993 to 2002. Participants Biopsies of 124 consecutive nasopharyngeal carcinoma patients without initial distant metastasis and treated with consistent guidelines were assessed. Immunoexpressions of EMP2 were analysed and the outcomes were correlated with clinicopathological features and patient survivals. Primary and secondary outcome measures Immunoexpressions of EMP2 were analyzed and the outcomes were correlated with clinicopathological features and patient survivals. Results Loss of EMP2 expression (49.2%) was correlated with advanced primary tumour (p=0.044), nodal status (p=0.045) and the 7th American Joint Committee on Cancer stage (p=0.027). In multivariate analyses, loss of EMP2 expression emerged as an independent prognosticator for worse disease-specific survival (DSS; p=0.015) and local recurrence-free survival (LRFS; p=0.030), along with the American Joint Committee on Cancer stages III–IV (p=0.034, DSS; p=0.023, LRFS). Conclusions Loss of EMP2 expression is common and associated with adverse prognosticators and might confer tumour aggressiveness through hampering its interaction with specific membrane protein(s) and hence the downstream signal transduction pathway(s).Keywords
This publication has 37 references indexed in Scilit:
- Mechanisms of integrin activation and traffickingCurrent Opinion in Cell Biology, 2011
- Correlation of Skp2 overexpression to prognosis of patients with nasopharyngeal carcinoma from South ChinaChinese Journal of Cancer, 2011
- Nasopharyngeal carcinoma: The next challengesEuropean Journal of Cancer, 2010
- Expression of epithelial membrane protein‐2 is associated with endometrial adenocarcinoma of unfavorable outcomeCancer, 2006
- Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell deathClinical Immunology, 2003
- Epithelial Membrane Proteins Induce Membrane Blebbing and Interact with the P2X7 Receptor C TerminusJournal of Biological Chemistry, 2002
- Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Characterization of Integrin–Tetraspanin Adhesion ComplexesJournal of Cell Biology, 1999
- Nasopharyngeal carcinoma: the Epstein-Barr virus association.1994